News & Blog
-
News
20 June 2018
Ovarian Cancer Action receives £150,000 at NEX Giving Day
Ovarian Cancer Action was honoured to have been nominated as one of the six chosen charities for the first NEX Giving Day, held in London on 7th June.
-
Blog
18 June 2018
"Before I was told I was BRCA positive, I had very limited knowledge of what it was"
Andrea is 40, and mum to three girls. She recently discovered both she and her youngest daughter are BRCA2 positive.
-
News
15 June 2018
Ovarian Cancer Action scientists discover mechanism that ‘deactivates’ ovarian cancer cells
Scientists at the Ovarian Cancer Action Research Centre at Imperial College London have discovered a mechanism that deactivates ovarian cancer cells, which could lead to better treatments for women with ovarian cancer.
-
Your Stories
12 June 2018
Rachel Firmin
Rachel pushed for genetic testing after losing her mum to breast cancer and discovered that she was BRCA2+. She shares her story.
-
News
10 June 2018
Ovarian Cancer Action launches Hereditary Cancer Risk Tool
This week sees the launch of Ovarian Cancer Action's Hereditary Cancer Risk Tool, which has been developed to help people identify their cancer risk. We believe everyone has the right to understand if their family history puts them at risk of ovarian and other cancers, as well as the risk-reducing options available.
-
Blog
06 June 2018
"Sarah was very lucky to have been diagnosed in the early stages"
Andy’s wife Sarah was diagnosed with stage 2 ovarian cancer in 2008. He shares their story to help raise awareness of the importance of early detection and to highlight why an ovarian cancer screening tool is so desperately needed.
-
News
01 June 2018
'Breakthrough' blood test could detect ovarian cancer in its earliest stages
In today’s news, a blood test has been hailed a ‘possible holy grail’ in the early detection of ovarian cancer. The...
-
News
01 June 2018
Ovarian cancer drug Niraparib approved for NHS use
The National Institute for Health and Care Excellence (NICE) have today announced that a new drug, Niraparib, has been recommended for use in the Cancer Drugs Fund as an option for maintenance treatment of platinum-sensitive relapsed high grade serous epithelial ovarian cancer.
-
News
30 May 2018
What is patient data and how can it help cancer research?
This month marks a big change in health services as the NHS introduces a new national data opt-out service to give patients more control over how their personal information is used. We take a look at the new system and how data acts as a powerful tool in cancer research.
-
News
22 May 2018
Artificial intelligence to improve cancer diagnosis
Ovarian Cancer Action welcomes today’s announcement from the Prime Minister to use emerging technologies to transform cancer diagnosis in the UK, saving around 22,000 lives a year by 2033.
-
Blog
21 May 2018
"One of the first things I wanted to do once I was in remission was to get fit again"
Keen cyclist Dominique was teaching English in Myanmar when she was diagnosed with ovarian cancer. Now in remission, she explains why it has been so important to her to get back in the saddle.
-
News
15 May 2018
Scientists identify cause of resistance to ovarian and breast cancer drug
Scientists at the Institute of Cancer Research have identified a genetic mutation that causes cancer cells to become resistant to PARP inhibitors, such as olaparib, which are used to treat ovarian and breast cancers.
-
News
08 May 2018
APPG publishes report on early diagnosis of ovarian cancer
The Ovarian Cancer All-Party-Parliamentary-Group (APPG) has today published a report “Diagnosing ovarian cancer sooner: what more can be done?” to mark World Ovarian Cancer Day.
-
News
04 May 2018
World Ovarian Cancer Day 2018: 7,400 roses
Tuesday 8th May is World Ovarian Cancer Day and we’re joining forces with ovarian cancer communities from around the globe to raise awareness of the disease and highlight the need to fund research.
-
Blog
03 May 2018
"Getting back to fitness has not been easy but I'm determined that I'll conquer this ride"
This time last year Rosie couldn't walk 1km without a rest, yet alone contemplate riding her bike, as she was just completing six cycles of chemotherapy for ovarian cancer. Now she is gearing up to take on Ride the Night for Women V Cancer.
-
Blog
25 April 2018
"Running a marathon is a fitting tribute to my strong, courageous mum"
Helen Witter ran the Manchester marathon on 8th April this year aged 61. It is the third time she has competed in the event. She tells us about her experience.
-
Blog
13 April 2018
OCAM 2018: We couldn't have done it without you!
March has come to an end and what a month it has been! Thank you to all of our wonderful supporters for taking action to help us get closer to our goal to raise £1 million to fund an ovarian cancer screening tool. Read on for some of our Ovarian Cancer Awareness Month highlights...
-
Blog
02 April 2018
Running for friendship: the road to the London Marathon
Liz is running the London Marathon this April as part of #TeamOCA. Undeterred by the recent snow, she tells us about her motivation behind running and fundraising for Ovarian Cancer Action
-
Blog
29 March 2018
"My wife, daughters and I decided that we should be open and honest with one another"
Paramjit’s wife Ravi was first diagnosed with ovarian cancer in 2007, eventually losing her battle in May 2017. He shares his story to help raise awareness of the importance of early detection and to encourage women to be persistent with their GP if they are experiencing symptoms.
-
Blog
26 March 2018
"If we are to make a major difference in our fight against ovarian cancer we must develop a screening tool"
We created our Stolen Moments campaign with the aim of raising £1 million to fund research into a screening tool. Your generous support is helping fund work by Professor Ahmed Ahmed's team at University of Oxford. We spoke to him about his vital research into early detection and the discoveries his team have made so far.